Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Non Operating Investment Income: 2015-2023

Historic Non Operating Investment Income for Ironwood Pharmaceuticals (IRWD) over the last 9 years, with Dec 2023 value amounting to $19,000.

  • Ironwood Pharmaceuticals' Non Operating Investment Income fell 97.40% to $19,000 in Q1 2023 from the same period last year, while for Mar 2023 it was -$529,000, marking a year-over-year increase of 81.36%. This contributed to the annual value of $19,000 for FY2023, which is 89.56% down from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Non Operating Investment Income of $19,000 as of FY2023, which was down 89.56% from $182,000 recorded in FY2022.
  • Over the past 5 years, Ironwood Pharmaceuticals' Non Operating Investment Income peaked at $3.0 million during FY2019, and registered a low of -$6.1 million during FY2020.
  • In the last 3 years, Ironwood Pharmaceuticals' Non Operating Investment Income had a median value of $19,000 in 2023 and averaged -$325,667.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Non Operating Investment Income soared by 134.58% in 2019 and then crashed by 302.75% in 2020.
  • Ironwood Pharmaceuticals' Non Operating Investment Income (Yearly) stood at $3.0 million in 2019, then tumbled by 302.75% to -$6.1 million in 2020, then surged by 80.78% to -$1.2 million in 2021, then skyrocketed by 115.45% to $182,000 in 2022, then crashed by 89.56% to $19,000 in 2023.